Interventions to improve outcomes in community-acquired pneumonia

Expert Rev Anti Infect Ther. 2023 Jul-Dec;21(10):1071-1086. doi: 10.1080/14787210.2023.2257392. Epub 2023 Sep 14.

Abstract

Introduction: Community-acquired pneumonia (CAP) is a common infection associated with high morbimortality and a highly deleterious impact on patients' quality of life and functionality. We comprehensively review the factors related to the host, the causative microorganism, the therapeutic approach and the organization of health systems (e.g. setting for care and systems for allocation) that might have an impact on CAP-associated outcomes. Our main aims are to discuss the most controversial points and to provide some recommendations that may guide further research and the management of patients with CAP, in order to improve their outcomes, beyond mortality.

Area covered: In this review, we aim to provide a critical account of potential measures to improve outcomes of CAP and the supporting evidence from observational studies and clinical trials.

Expert opinion: CAP is associated with high mortality and a highly deleterious impact on patients' quality of life. To improve CAP-associated outcomes, it is important to understand the factors related to the patient, etiology, therapeutics, and the organization of health systems.

Keywords: Pneumonia; community-acquired pneumonia; outcomes; respiratory infection; severe pneumonia.

Publication types

  • Review

MeSH terms

  • Community-Acquired Infections* / drug therapy
  • Humans
  • Pneumonia* / drug therapy
  • Quality of Life